DE2701237A1 - Naphthalinon-phthalazinylhydrazone, verfahren zu ihrer herstellung und arzneimittel - Google Patents

Naphthalinon-phthalazinylhydrazone, verfahren zu ihrer herstellung und arzneimittel

Info

Publication number
DE2701237A1
DE2701237A1 DE19772701237 DE2701237A DE2701237A1 DE 2701237 A1 DE2701237 A1 DE 2701237A1 DE 19772701237 DE19772701237 DE 19772701237 DE 2701237 A DE2701237 A DE 2701237A DE 2701237 A1 DE2701237 A1 DE 2701237A1
Authority
DE
Germany
Prior art keywords
phthalazinyl
general formula
naphthalenone
dihydro
hydrazone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19772701237
Other languages
German (de)
English (en)
Inventor
Glenn C Morrison
Lawrence D Wise
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of DE2701237A1 publication Critical patent/DE2701237A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/34Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE19772701237 1976-02-12 1977-01-13 Naphthalinon-phthalazinylhydrazone, verfahren zu ihrer herstellung und arzneimittel Withdrawn DE2701237A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/657,436 US4061636A (en) 1976-02-12 1976-02-12 Naphthalenone phthalazinylhydrazones

Publications (1)

Publication Number Publication Date
DE2701237A1 true DE2701237A1 (de) 1977-08-25

Family

ID=24637180

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772701237 Withdrawn DE2701237A1 (de) 1976-02-12 1977-01-13 Naphthalinon-phthalazinylhydrazone, verfahren zu ihrer herstellung und arzneimittel

Country Status (8)

Country Link
US (1) US4061636A ( )
JP (1) JPS5297985A ( )
AU (1) AU2157877A ( )
CA (1) CA1083151A ( )
DE (1) DE2701237A1 ( )
DK (1) DK59277A ( )
FR (1) FR2340936A1 ( )
GB (1) GB1508118A ( )

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2517039A (en) * 1947-02-07 1950-08-01 Gen Fireproofing Co Folding lounge chair
US6821974B2 (en) 2002-03-05 2004-11-23 Barbeau Pharma, Inc Stable pharmaceutical compositions
US6825196B2 (en) * 2002-03-05 2004-11-30 Barbeau Pharma, Inc. Stable pharmaceutical compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3274185A (en) * 1963-10-08 1966-09-20 S E Massengill Company Phthalazine derivatives
US3840539A (en) * 1970-09-14 1974-10-08 Daiichi Seiyaku Co Phthalazine derivatives

Also Published As

Publication number Publication date
DK59277A (da) 1977-08-13
CA1083151A (en) 1980-08-05
AU2157877A (en) 1978-08-03
GB1508118A (en) 1978-04-19
FR2340936B1 ( ) 1981-01-09
US4061636A (en) 1977-12-06
JPS5297985A (en) 1977-08-17
FR2340936A1 (fr) 1977-09-09

Similar Documents

Publication Publication Date Title
DE2408804C2 (de) 1-(2-Methoxyphenyl)-4-[3-(naphth-1-yl-oxy)-2-hydroxy-propyl]-piperazin, dessen Salze, Verfahren zu ihrer Herstellung sowie Arzneimittel, die diese Verbindungen enthalten
DE3047142C2 (de) Basische 1,7,7-Trimethylbicyclo[2,2,1]heptyläther, Verfahren zur Herstellung derselben und diese enthaltende Arzneimittel
DE3689369T2 (de) Terpen-amino-Alkohole und deren medizinische Verwendung.
DE1543714A1 (de) Verfahren zur Herstellung von aminoalkyl-substituierten Phthalanen und Isochromanen
DE69126433T2 (de) 1,4-disubstituierte piperazine
EP0243904A1 (de) Gegebenenfalls substituierte, 1-(2'-[bis-(Phenyl)-methoxy]-äthyl)-4-(3'-[bis-(phenyl)-methoxy]-propyl)-piperazine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE69311566T2 (de) Heterocyclische amine als calmodulin antagonisten
CH615410A5 (en) Process for the preparation of novel alpha-ethylbenzhydrol derivatives
DE60104986T2 (de) Xanthinderivate, Zwischenprodukte und Verwendung zur Behandlung von Osteoporose
DE2701237A1 (de) Naphthalinon-phthalazinylhydrazone, verfahren zu ihrer herstellung und arzneimittel
DE1925956B2 (de) 4- [3-(subst- Amino)-2-hydroxypropoxy] -1,2,5thiadiazolverbindungen und ein diese Verbindungen enthaltendes pharmazeutisches Mittel
EP0435902B1 (de) 2-hydroxy-3-phenoxy-propyl-substituierte piperazine, ihre herstellung und verwendung
CH640234A5 (de) Verfahren zur herstellung neuer heterocyclischer verbindungen.
DE1901519A1 (de) Chinazolinylharnstoffe
DE1793386A1 (de) Flavonverbindungen und Verfahren zu ihrer Herstellung
DD297402A5 (de) Neue aminopropanol-derivate, diese verbindungen als wirkstoff enthaltende arzneimittelpraeparate sowie verfahren zur herstellung derselben
CH635312A5 (de) Alpha-aryl-alpha,alpha-bis(omega-(disubstituierte amino)-alkyl)acetamide und deren saeureanlagerungssalze, verfahren zu ihrer herstellung sowie sie enthaltende arzneimittelzubereitungen.
DE3101093C2 ( )
US2642432A (en) Lower alkyl 4-substituted-2-(tertiary-aminoalkoxy) benzoates and their preparation
AT389872B (de) Verfahren zur herstellung von neuen substituierten 2-phenylmethylen-1aminoalkyloximinocycloalkanen und deren saeureadditionssalzen
DE2931319A1 (de) 6-methoxy-2-acetylnaphthalinoxim- derivate, verfahren zu ihrer herstellung sowie sie enthaltende arzneimittel
CH615665A5 (en) Process for the preparation of the Z-isomer of 3-(4-bromophenyl)-N-methyl-3-(3-pyridyl)allylamine
DE2725245A1 (de) Methylaminderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische oder veterinaermedizinische zusammensetzungen
EP0115079B1 (de) Substituierte 1-((3-(Amino)-propoxy)-phenyl)-1-(phenyl)-propan-1-ole, ihre Säureadditionssalze und quaternären Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
WO1993020814A1 (de) Immunaktivierende und damit antivirale wirking von 4-[3-(subst.-amino)-2-hydroxypropoxy]-1,2,5-thiadiazolverbindungen

Legal Events

Date Code Title Description
8130 Withdrawal